What Are the Benefits, Uses, and Potential Side Effects of Shujin Wan?
Shujin Wan is a traditional Chinese herbal formulation historically used to promote circulation, alleviate muscle and joint stiffness, and relieve pain associated with wind-damp obstruction patterns i
Shujin Wan is a traditional Chinese herbal formulation historically used to promote circulation, alleviate muscle and joint stiffness, and relieve pain associated with wind-damp obstruction patterns in Traditional Chinese Medicine (TCM). Its typical composition includes processed Aconiti Lateralis Radix Praeparata (Fuzi), Angelicae Pubescentis Radix (Duhuo), Gentianae Macrophyllae Radix (Qinjiao), and other herbs selected for their purported ability to dispel wind, eliminate dampness, and invigorate blood flow.
Clinically, Shujin Wan has been employed—often as an adjunct therapy—for conditions such as osteoarthritis, rheumatoid arthritis, lumbar strain, and post-traumatic musculoskeletal discomfort. However, robust clinical trial evidence supporting its efficacy remains limited. Most existing data derive from observational studies or small-scale trials conducted in China, and findings have not been consistently replicated in rigorous, placebo-controlled, multicenter investigations.
The most significant safety concern relates to its inclusion of processed aconite root, which contains cardiotoxic diterpenoid alkaloids—including mesaconitine, hypaconitine, and aconitine—even after detoxification procedures. Inappropriate dosing, prolonged use, or concomitant use with other cardiotoxic agents may precipitate life-threatening arrhythmias, ventricular tachycardia, or asystole. Other reported adverse effects include gastrointestinal distress (nausea, vomiting, abdominal pain), dizziness, paresthesia, and elevated liver enzymes. Cases of acute hepatotoxicity and renal impairment have also been documented in post-marketing surveillance.
Due to these risks, regulatory authorities—including China’s National Medical Products Administration (NMPA) and the U.S. Food and Drug Administration (FDA)—have issued warnings against unsupervised use. Shujin Wan is contraindicated in patients with preexisting cardiac disease, hepatic or renal insufficiency, pregnancy, lactation, and in children. It should never be self-administered; use requires evaluation and ongoing monitoring by a qualified healthcare provider trained in both TCM and integrative medicine principles.